Education
About Us
Working with TipRanks
Follow Us
John Mcmullan Insider Profile
4 Followers
John Mcmullan, Medical Director at Totally, holds 7.11M shares in Totally (Ticker: GB:TLY). Most recently, John Mcmullan Bought 4,167,178p shares of Totally on Mar 24, 2025 for an estimated value of 143.77K.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-81.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
John Mcmullan does not currently own shares as a corporate insider.
A breakdown of John Mcmullan's holdings
Insider Roles
John Mcmullan does not currently hold a role as a corporate insider.
Roles that John Mcmullan holds in companies
Most Profitable Insider Trade
Stock:
Totally
(TLY)
(TLY)
Rating:Informative Buy
Date:Mar 08, 2023 - Mar 08, 2024
Return:-69.60%
The most profitable trade made by John Mcmullan
John Mcmullan's Trading History
List of latest transactions for each holding click on a transaction to see John Mcmullan's performance on stock
You May Also Like
John Mcmullan insider profile FAQ
What is the percentage of profitable transactions made by John Mcmullan?
The percentage of profitable transactions made by John Mcmullan is 0%.
What is the average return per transaction made by John Mcmullan?
The average return per transaction made by John Mcmullan is -81.90%.
What stocks does John Mcmullan hold?
John Mcmullan holds: GB:TLY stocks.
What was John Mcmullan’s latest transaction?
John Mcmullan latest transaction was an Informative Buy of 143.77K.
What was John Mcmullan's most profitable transaction?
John Mcmullan’s most profitable transaction was an Informative Buy of GB:TLY stock on March 8, 2023. The return on the trade was -69.60%.
What is John Mcmullan's role in Totally?
John Mcmullan's role in Totally is Medical Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.